Sandoz Group (OTCMKTS:SDZNY) Sees Large Volume Increase – Here’s What Happened

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY) shares saw unusually-high trading volume on Wednesday . 47,894 shares traded hands during mid-day trading, an increase of 55% from the previous session’s volume of 30,840 shares.The stock last traded at $85.18 and had previously closed at $79.32.

Analysts Set New Price Targets

Separately, Barclays upgraded shares of Sandoz Group from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 5th. Three research analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Strong Buy”.

Sandoz Group Trading Up 5.8%

The stock’s fifty day moving average price is $83.50 and its two-hundred day moving average price is $82.58. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.18 and a quick ratio of 0.77.

About Sandoz Group

Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.

The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.